Skyepharma's new HPAPI zone
To mark the opening of their new HPAPI zone for OEB 4/5+ molecules, Skyepharma is hosting their first Scientific Symposium on February 6th, 2025. This event, titled “Recent Advances in Overcoming Oral Solid Dosage Form Development Current Challenges,” will bring together industry experts to discuss the latest innovations and challenges in oral solid dosage form development.
MEDELPHARM's contribution: STYL'One Evo DryCon®
We are excited to announce that MEDELPHARM has installed a STYL'One Evo DryCon® Compaction Simulator in Skyepharma's new HPAPI zone. This state-of-the-art equipment is designed to handle HPAPIs safely, ensuring both operator protection and precision in formulation development.
Key features of the STYL'One Evo DryCon
- High Containment: Advanced containment solutions, including negative pressure control, air filtration, and safe cleaning protocols
- Versatility: Capable of producing single-layer and multi-layer tablets, handling up to five layers with three different products
- Simulation Capabilities: Replicates high compression speeds of large production rotary presses for seamless scale-up and production support
- Software Integration: Analis software provides precise control and analysis of the tableting process

As part of the symposium, Quentin Boulay, Marketing Director from MEDELPHARM will share insights on "STYL'One Compaction Simulators: a tool for accelerated tablet development and efficient production support.” This presentation will highlight how the STYL'One Evo can accelerate tablet development and enhance production efficiency, even in HPAPI-based therapies.
Why containment matters
With the increasing use of HPAPIs, high-containment solutions at the lab scale are essential. Key considerations include ensuring safety without compromising efficiency, meeting strict containment standards, and simplifying cleaning and maintenance processes. The STYL'One Evo DryCon® addresses these challenges, providing both operator protection and precision in formulation development.
At MEDELPHARM, we are committed to advancing pharmaceutical development through innovative solutions. Our Science Lab is equipped with a range of STYL'One models, including the STYL'One Evo, Nano, and Evo DryCon®, to support our customers' needs from R&D to production. We offer comprehensive services, including powder characterization, formulation development support, scale-up, and consulting.
Join us at Skyepharma's symposium to learn more about the latest advancements in HPAPI development and how the STYL'One Evo DryCon® can support your pharmaceutical projects. Follow the event live on YouTube.
Conclusion
For more information on our products and services, visit our website or contact us directly. Together, we can drive innovation in pharmaceutical development and manufacturing.